Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620984 · ClinicalTrials.gov registry record
Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 557
- Enrollment target
NCT00620984: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT00620984 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 557 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00620984 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 557 participants
- Enrollment target
Study Summary
Lactation (breastfeeding) mastitis is an acute infection of the milk ducts of the breastfeeding woman. Staphylococcus aureus (S. aureus) is the infectious germ most commonly associated with lactation mastitis. Twenty percent of the general population are carriers of Staphylococcus aureus, which means that they carry the infectious germ but do not become ill from it. It has been suggested that mothers who are carriers of S. aureus in their nostril may be at an increased risk of developing lactational mastitis, however; this has not been clinical proven. We are studying the relationship between S. aureus carrier status of breastfeeding mothers and infants and the risk of developing lactational mastitis. Additionally, we are collecting questionnaire data in an attempt to better define factors predisposing women to lactation mastitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 557 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-12 |
What the finished NCT00620984 record still lists
NCT00620984 is an observational study that tracks outcomes without assigning an intervention. The registered 557 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00620984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00620984 about?
NCT00620984 is a clinical study titled "Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis". Lactation (breastfeeding) mastitis is an acute infection of the milk ducts of the breastfeeding woman. Staphylococcus aureus (S. aureus) is the infectious germ most commonly associated with lactation mastitis. Twenty percent of the general population are carriers of Staphylococcus aureus, which mean...
What is the current status of trial NCT00620984?
This trial is currently completed. The enrollment target is 557 participants. The study started on 2006-08. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00620984?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT07173751 · 558 participants · Phase 3
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia